Report of the International Consensus Development Conference on Female Sexual Dysfunction: Definitions and Classifications

@article{Basson2001ReportOT,
  title={Report of the International Consensus Development Conference on Female Sexual Dysfunction: Definitions and Classifications},
  author={R. Basson and J. Berman and A. Burnett and L. Derogatis and D. Ferguson and J. Fourcroy and I. Goldstein and A. Graziottin and J. Heiman and E. Laan and S. Leiblum and H. Padma-nathan and R. Rosen and K. Segraves and R. Segraves and R. Shabsigh and M. Sipski and G. Wagner and B. Whipple},
  journal={Journal of Sex \& Marital Therapy},
  year={2001},
  volume={27},
  pages={83 - 94}
}
83 Address correspondence to Rosemary Basson, Echelon Bldg., Vancouver Hospital, 855 W. 12th Avenue, Vancouver, B.C., Canada V5Z 1M9. E-mail: sexmed@interchange.ubc.ca Supported by the Sexual Function Health Council of the American Foundation for Urologic Disease through educational grants provided by Affiliated Research Centers, Eli Lilly/ICOS Pharmaceuticals, Pentech Pharmaceuticals, Pfizer Inc., Procter & Gamble, Schering-Plough, Solway Pharmaceuticals, TAP Pharmaceuticals, and Zonagen… Expand
Invited Review Shoulder Pain In Chronic Spinal Cord Injury, Part 1: Epidemiology, Etiology, And Pathomechanics
TLDR
Little research has examined the reproductive issues of women with spina bifida and women with other neurologic disabilities, and future controlled prospective research studies are needed to examine issues related to puberty and sexual and gynecologic issues throughout the life span and pregnancy in these populations. Expand
Use of Sildenafil for Female Sexual Dysfunction
TLDR
It appears that sildenafil, while well tolerated, offers little or no benefit to most patients with FSD and should include both physical and psychological components in treatment. Expand
Strategic Planning in Research and Development Is Needed in Female Sexual Dysfunction
  • R. Shabsigh
  • Psychology, Medicine
  • Journal of sex & marital therapy
  • 2001
TLDR
A wellfocused, step-wise, and properly prioritized plan for research in FSD will help academic centers organize their efforts and guide the pharmaceutical industry to employ its resources fruitfully. Expand
Managing Female Sexual Dysfunction in the 21 st Century Dr .
The invention of the "blue pill" revolutionised the management of male erectile dysfunction in the past ten years and raised optimism about a quick fix for other sexual problems. Despite significantExpand
Penetration Disorder: Dyspareunia Exists on the Extension of Vaginismus
  • K. Kaneko
  • Medicine, Psychology
  • Journal of sex & marital therapy
  • 2001
TLDR
A new definition and diagnosis of female sexual dysfunction was proposed at the 14th World Congress of Sexology at Hong Kong in 1999 and the author described its points and comment on your report. Expand
Dyspareunia : clinical approach in the perimenopause
Dyspareunia has long been considered to be psychogenic. Opposite, it has solid biological bases, that need to be addressed in a more integrated and patient-centered perspective. The new InternationalExpand
Update on female sexual function
TLDR
The studies reviewed highlight a number of important methodological and etiological issues in the study of female sexual function, and suggest that free testosterone levels may be associated with sexual desire in women. Expand
Assessing the Clinical Efficacy of Sildenafil for the Treatment of Female Sexual Dysfunction
TLDR
Although data suggest a possible role of sildenafil for the treatment of FSD, the information should be interpreted cautiously, as many of the studies included small sample sizes, used inappropriate statistical tests, and used nonvalidated assessment tools. Expand
Progress in Female Sexual Dysfunction
TLDR
The knowledge in this field of FSD is quite limited, there is still no approved therapy, and future advances in evaluation and treatment of female sexual problems are forthcoming. Expand
A New Non-Pharmacological Vacuum Therapy for Female Sexual Dysfunction
TLDR
The objective of this study was to assess the effectiveness of the EROS-CTD on sexual arousal (genital sensation, vaginal lubrication, ability to reach orgasm, and sexual satisfaction) in normal volunteers and women with FSD. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 22 REFERENCES
The process of care model for evaluation and treatment of erectile dysfunction
  • R. Rosen
  • Medicine
  • International Journal of Impotence Research
  • 1999
TLDR
The panel strongly recommends further research into the causes and associated risk factors for erectile dysfunction, prevention and the role of lifestyle modification, and the critical issue of partner-related sexual dysfunction. Expand
Sexual dysfunction in the United States: prevalence and predictors.
TLDR
The results indicate that sexual dysfunction is an important public health concern, and emotional problems likely contribute to the experience of these problems. Expand
Prevalence of sexual dysfunction in women: results of a survey study of 329 women in an outpatient gynecological clinic.
TLDR
Age and relationship status were significant predictors of sexual satisfaction, with older women and singles reporting a higher incidence of sexual problems, and educational level, religious affiliation, and employment status were not predictive of sexual dysfunction in the present study. Expand
Definition and classification of female sexual disorders.
  • S. Leiblum
  • Medicine
  • International journal of impotence research
  • 1998
TLDR
Hypoactive sexual desire disorder is the most commonly diagnosed female sexual disorder followed by female orgasmic disorder, and the major clinical complaints among women center on their dissatisfaction with such non-genital behaviors as affection, communication, and non- genital touching. Expand
Classification of sexual dysfunctions: towards DSM-V and ICD-11.
TLDR
The changes in the classification of sexual dysfunctions since DSM-III, and on the results of the efforts to make these disorders compatible in DSM-IV and ICD-10, are reported. Expand
Vasculogenic female sexual dysfunction: vaginal engorgement and clitoral erectile insufficiency syndromes.
TLDR
There is a growing body of evidence that women with sexual dysfunction will commonly have physiologic abnormalities, such as vasculogenic female sexual dysfunction, contributing to their overall sexual health problems. Expand
Self-report assessment of female sexual function: Psychometric evaluation of the brief index of sexual functioning for women
TLDR
The Brief Index of Sexual Functioning for Women (BISF-W), a 22-item, self-report instrument for the assessment of current levels of female sexual functioning and satisfaction, was developed and compared to the Brief Sexual Function Questionnaire. Expand
The DSFI: a multidimensional measure of sexual functioning.
The present report summarizes work to date on the Derogatis Sexual Functioning Inventory (DSFI), a multidimensional measure of human sexual functioning. We discuss the rationale for the test as wellExpand
Measuring the Clinical Appropriateness of the Use of a Procedure Can We Do It?
TLDR
A method to judge the clinical appropriateness of services was developed and tested in two large, urban geographic areas and showed 99% agreement on items abstracted from a subset of records independently reviewed by two abstractors. Expand
Hypoactive sexual desire disorder: prevalence and comorbidity in 906 subjects.
The frequency of hypoactive sexual desire disorder (HSDD) and the frequency of comorbidity of sexual disorders was recorded from a total population of 906 subjects studied in a multisiteExpand
...
1
2
3
...